CUSIP: 36118A100
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,899,434
-
Share change
-
-331,843
-
Total reported value
-
$129,738,352
-
Price per share
-
$2.60
-
Number of holders
-
39
-
Value change
-
-$960,412
-
Number of buys
-
11
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP 36118A100:
Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q3 2023
As of 30 Sep 2023,
FUSION PHARMACEUTICALS INC - COM (FUSN) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,899,434 shares.
The largest 10 holders included
FEDERATED HERMES, INC., Avidity Partners Management LP, FMR LLC, JOHNSON & JOHNSON, ORBIMED ADVISORS LLC, CANADA PENSION PLAN INVESTMENT BOARD, ADAMS STREET PARTNERS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PERCEPTIVE ADVISORS LLC, and TPG GP A, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.